344 related articles for article (PubMed ID: 12920414)
1. Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: polysomnographic and clinical evaluations.
Le Bon O; Murphy JR; Staner L; Hoffmann G; Kormoss N; Kentos M; Dupont P; Lion K; Pelc I; Verbanck P
J Clin Psychopharmacol; 2003 Aug; 23(4):377-83. PubMed ID: 12920414
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of alcohol withdrawal with trazodone.
Borras L; de Timary P; Constant EL; Huguelet P; Eytan A
Pharmacopsychiatry; 2006 Nov; 39(6):232. PubMed ID: 17124647
[TBL] [Abstract][Full Text] [Related]
3. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
4. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
Munizza C; Olivieri L; Di Loreto G; Dionisio P
Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
[TBL] [Abstract][Full Text] [Related]
5. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
6. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
7. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients.
Zavesicka L; Brunovsky M; Horacek J; Matousek M; Sos P; Krajca V; Höschl C
Neuro Endocrinol Lett; 2008 Dec; 29(6):895-901. PubMed ID: 19112384
[TBL] [Abstract][Full Text] [Related]
8. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients.
Scharf MB; Sachais BA
J Clin Psychiatry; 1990 Sep; 51 Suppl():13-7. PubMed ID: 2211559
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
10. Sleep electroencephalographic spectral power after withdrawal from alcohol in alcohol-dependent patients.
Feige B; Scaal S; Hornyak M; Gann H; Riemann D
Alcohol Clin Exp Res; 2007 Jan; 31(1):19-27. PubMed ID: 17207097
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of trazodone in the treatment of insomnia].
Gałecki P; Florkowski A; Talarowska M
Pol Merkur Lekarski; 2010 Jun; 28(168):509-12. PubMed ID: 20642116
[TBL] [Abstract][Full Text] [Related]
13. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
[TBL] [Abstract][Full Text] [Related]
14. Nefazodone in primary insomnia: an open pilot study.
Wiegand MH; Galanakis P; Schreiner R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
[TBL] [Abstract][Full Text] [Related]
15. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
[TBL] [Abstract][Full Text] [Related]
16. Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares.
Warner MD; Dorn MR; Peabody CA
Pharmacopsychiatry; 2001 Jul; 34(4):128-31. PubMed ID: 11518472
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
18. [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use].
Wichniak A; Wierzbicka A; Sobańska A; Szatkowska E; Czasak K; Musińska I; Jernajczyk W
Pol Merkur Lekarski; 2007 Jul; 23(133):41-6. PubMed ID: 18051828
[TBL] [Abstract][Full Text] [Related]
19. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
Blumer JL; Findling RL; Shih WJ; Soubrane C; Reed MD
Pediatrics; 2009 May; 123(5):e770-6. PubMed ID: 19403468
[TBL] [Abstract][Full Text] [Related]
20. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
